133 related articles for article (PubMed ID: 1824189)
1. Experimental study on the electrophysiological effects of the combination of the antiarrhythmic drugs aprindine and verapamil.
Okishige K; Ohtomo K; Satoh T; Hiejima K
Arch Int Pharmacodyn Ther; 1991; 314():44-56. PubMed ID: 1824189
[TBL] [Abstract][Full Text] [Related]
2. Effects of aprindine HCL on cardiac tissues.
Elharrar V; Foster PR; Zipes DP
J Pharmacol Exp Ther; 1975 Nov; 195(2):201-5. PubMed ID: 1185591
[TBL] [Abstract][Full Text] [Related]
3. [Electrophysiological effects of anti-arrhythmia agents in man. Attempt at classification].
Touboul P; Attalah G; Gressard A; Michelon G; Chatelain MT; Delahaye JP
Arch Mal Coeur Vaiss; 1979 Jan; 72(1):72-81. PubMed ID: 107885
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological effects of penticainide in the anaesthetized dog.
Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
[TBL] [Abstract][Full Text] [Related]
5. Cardiac conduction interactions of propranolol and verapamil with halothane in pentobarbitone-anaesthetized dogs.
Hart AP; Royster RL; Johnston WE
Br J Anaesth; 1988 Dec; 61(6):748-53. PubMed ID: 3207546
[TBL] [Abstract][Full Text] [Related]
6. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction.
Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K
Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic evaluation of intravenous verapamil in man.
Rizzon P; Di Biase M; Calabrese P; Brindicci G; Chiddo A
Eur J Cardiol; 1977; 6(3):179-94. PubMed ID: 338305
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological effects of carocainide (770207) on the dog heart.
Huerta F; Santamaria R; Pourrias B
Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):289-98. PubMed ID: 6712362
[TBL] [Abstract][Full Text] [Related]
9. [Effects of injectable aprindine in dogs, with special reference to the recording of atrial and ventricular monophasic action potentials and the bundle of His electrogram].
Puech P; Cabasson J; Mellet JM; Guimond C
Therapie; 1974; 29(5):731-40. PubMed ID: 4462224
[No Abstract] [Full Text] [Related]
10. A study of the verapamil-induced changes in conductivity and refractoriness and monophasic action potentials of the dog heart in situ.
Landmark K; Amlie JP
Eur J Cardiol; 1976 Dec; 4(4):419-27. PubMed ID: 1001337
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
Leboeuf J; Basiez M; Massingham R
Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
[TBL] [Abstract][Full Text] [Related]
12. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the electrophysiological effects of amiodarone using simultaneous recordings of monophasic and bundle-of-his action potentials].
Cabasson J; Puech P; Mellet JM; Guimond C; Bachy C; Sassine A
Arch Mal Coeur Vaiss; 1976 Jul; 69(7):691-9. PubMed ID: 821440
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
Pourrias B; Santamaria R
Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of verapamil against ventricular arrhythmias induced by programmed electrical stimulation in the late myocardial infarction phase in dogs.
Krejcy K; Krumpl G; Todt H; Raberger G
J Pharm Pharmacol; 1992 Apr; 44(4):349-54. PubMed ID: 1355549
[TBL] [Abstract][Full Text] [Related]
16. The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers.
Kinnaird AA; Man RY
Eur J Pharmacol; 1984 Mar; 99(1):63-71. PubMed ID: 6426981
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic effects of asocainol, a new antiarrhythmic agent with predominant class I action.
Thale J; Gülker H; Hagemense B; Rose D; Haverkamp W; Frenking B
Arzneimittelforschung; 1987 Jan; 37(1):14-6. PubMed ID: 3566851
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of the antiarrhythmic agent GYKI-23107 in dogs.
Szatmary LJ; Rabloczky G; Kurthy M; Varro A; Solti F
Acta Med Hung; 1988; 45(2):209-19. PubMed ID: 3247244
[TBL] [Abstract][Full Text] [Related]
19. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
Awaji T; Hashimoto K
J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
